Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
FDA warns about the risks of unproven surgical therapy for multiple sclerosis.
The feasibility of collecting information from people with Multiple Sclerosis for the UK MS Register via a web portal: characterising a cohort of people with MS.
Brain leukocyte infiltration initiated by peripheral inflammation or experimental autoimmune encephalomyelitis occurs through pathways connected to the CSF-filled compartments of the forebrain and midbrain.
Quantitative Proteomic Analysis of Human Substantia Nigra in Alzheimer's Disease, Huntington's Disease and Multiple Sclerosis.
Enhanced remyelination following lysolecithin-induced demyelination in mice under treatment with fingolimod (FTY720).
Disruption of nodal architecture in skin biopsies of patients with demyelinating neuropathies.
Fibrinogen: A Circulating Factor in Search for Its Genetic Architecture.
Carbon Nanotube-Bilirubin Oxidase Bioconjugate as a New Biofuel Cell Label for Self-Powered Immunosensor.
NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms.
Anti-drug antibodies: B-cell Immunity against therapy.
Treadmill Training or Progressive Strength Training to Improve Walking in People with Multiple Sclerosis? A Randomized Parallel Group Trial.
Role of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes.
Early netrin-1 expression impairs central nervous system remyelination.
To be 17 again--anti-interleukin-17 treatment for psoriasis.
Cognitive impairment and optic nerve axonal loss in patients with clinically isolated syndrome.
Images in clinical medicine. Bilateral internuclear ophthalmoplegia in multiple sclerosis.
Danish translation and psychometric testing of the Rivermead Mobility Index.
IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Water Extract from the Leaves of Withania somnifera Protect RA Differentiated C6 and IMR-32 Cells against Glutamate-Induced Excitotoxicity.
Paradoxical inflammation induced by anti-TNF agents in patients with IBD.
Efficacy and safety of beta-interferon in Thai patients with demyelinating diseases.
Clinical Importance of Steps Taken per Day among Persons with Multiple Sclerosis.
Concurrent Quantification of Tryptophan and Its Major Metabolites.
Perspectives on Physical Activity Among People with Multiple Sclerosis Who Are Wheelchair Users: Informing the Design of Future Interventions.
Modeling the variability in brain morphology and lesion distribution in multiple sclerosis by deep learning.
Pages
« first
‹ previous
…
339
340
341
342
343
344
345
346
347
…
next ›
last »